Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer

FASEB Journal

Volumn 26, Issue 8, 2012, Pages 3306-3320

  Cai, Qingchun ^a   Zhao, Zhenwen ^a,b   Antalis, Caryl ^a   Yan, Libo ^a   Del Priore, Giuseppe ^a   Hamed, Ali Hassan ^a   Stehman, Frederick B ^a   Schilder, Jeanne M ^a   Xu, Yan ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF CHEMISTRY   (China)

Author keywords

Ascites; Autotaxin; Methyl arachidonyl fluorophosphonate; Migration

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOTAXIN; BROMOENOL LACTONE; CALCIUM; HA 130; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; METHYL ARACHIDONYL FLUOROPHOSPHONATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CANCER MODEL; CARCINOGENESIS; CELL FREE SYSTEM; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MACROPHAGE; METASTASIS INHIBITION; MOUSE; NONHUMAN; OVARIAN TUMORIGENESIS; OVARY CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR GROWTH; TUMOR XENOGRAFT; VALIDATION PROCESS;

ANIMALS; ARACHIDONIC ACIDS; ASCITES; CELL LINE, TUMOR; FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHOLIPASES A2, SECRETORY; PHOSPHONIC ACIDS; PHOSPHORIC DIESTER HYDROLASES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84864740329     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-207597     Document Type: Article

References (46)

1. Xu, Y., Xiao, Y. J., Zhu, K., Baudhuin, L. M., Lu, J., Hong, G., Kim, K. S., Cristina, K. L., Song, L., F. S. W., Elson, P., Markman, M., and Belinson, J. (2003) Unfolding the pathophysiological role of bioactive lysophospholipids. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3, 23-32
2. Sengupta, S., Kim, K. S., Berk, M. P., Oates, R., Escobar, P., Belinson, J., Li, W., Lindner, D. J., Williams, B., and Xu, Y. (2007) Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene 26, 2894-2901 (Pubitemid 46701441)
3. Murph, M. M., Liu, W., Yu, S., Lu, Y., Hall, H., Hennessy, B. T., Lahad, J., Schaner, M., Helland, A., Kristensen, G., Borresen-Dale, A. L., and Mills, G. B. (2009) Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis. PLoS ONE 4, e5583
4. Aoki, J., Inoue, A., and Okudaira, S. (2008) Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 1781, 513-518
5. Murakami, M., Taketomi, Y., Sato, H., and Yamamoto, K. (2011) Secreted phospholipase A2 revisited. J. Biochem. 150, 233-255
6. Kudo, I., and Murakami, M. (2002) Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69, 3-58
7. Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M., De Medina, P., Monsarrat, B., Perret, B., Silvente-Poirot, S., Poirot, M., and Record, M. (2010) Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 51, 2105-2120
8. Iguchi, H., Kosaka, N., and Ochiya, T. (2010) Secretory microRNAs as a versatile communication tool. Commun. Integr. Biol. 3, 478-481
9. Cummings, B. S. (2007) Phospholipase A2 as targets for anticancer drugs. Biochem. Pharmacol. 74, 949-959
10. Scott, K. F., Sajinovic, M., Hein, J., Nixdorf, S., Galettis, P., Liauw, W., de Souza, P., Dong, Q., Graham, G. G., and Russell, P. J. (2010) Emerging roles for phospholipase A2 enzymes in cancer. Biochimie (Paris) 92, 601-610
11. Iorio, E., Ricci, A., Bagnoli, M., Pisanu, M. E., Castellano, G., Di Vito, M., Venturini, E., Glunde, K., Bhujwalla, Z. M., Mezzanzanica, D., Canevari, S., and Podo, F. (2010) Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res. 70, 2126-2135
12. Hendrix, N. D., Wu, R., Kuick, R., Schwartz, D. R., Fearon, E. R., and Cho, K. R. (2006) Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 66, 1354 -1362
13. Xu, Y., Wang, D., and Wang, Z. (2009) Lipid generation and signaling in ovarian cancer. In Cancer Treatment and Research-Ovarian Cancer (Stack, M. S., and Fishman, D. A., eds) pp. 241-268, Springer, New York, Dordrecht, Heidelberg, London
14. Song, Y., Wilkins, P., Hu, W., Murthy, K. S., Chen, J., Lee, Z., Oyesanya, R., Wu, J., Barbour, S. E., and Fang, X. (2007) Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells. Biochem. J. 406, 427-436 (Pubitemid 47425449)
15. Li, H., Zhao, Z., Wei, G., Yan, L., Wang, D., Zhang, H., Sandusky, G. E., Turk, J., and Xu, Y. (2010) Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development. FASEB J. 24, 4103-4116
16. Zhao, X., Wang, D., Zhao, Z., Xiao, Y., Sengupta, S., Xiao, Y., Zhang, R., Lauber, K., Wesselborg, S., Feng, L., Rose, T. M., Shen, Y., Zhang, J., Prestwich, G., and Xu, Y. (2006) Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells. J. Biol. Chem. 281, 29357-29368 (Pubitemid 44507079)
17. Wang, G., Pincheira, R., Zhang, M., and Zhang, J. T. (1997) Conformational changes of P-glycoprotein by nucleotide binding. Biochem. J. 328(Pt. 3), 897-904 (Pubitemid 28005791)
18. Zhao, Z., and Xu, Y. (2010) An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J. Lipid Res. 51, 652-659
19. Zhao, Z., and Xu, Y. (2009) Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 3739-3742
20. Xu, Y., Fang, X. J., Casey, G., and Mills, G. B. (1995) Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309(Pt. 3), 933-940
21. Sengupta, S., Xiao, Y. J., and Xu, Y. (2003) A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells. FASEB J. 17, 1570-1572
22. Xiao, Y. J., Schwartz, B., Washington, M., Kennedy, A., Webster, K., Belinson, J., and Xu, Y. (2001) Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal. Biochem. 290, 302-313 (Pubitemid 32217542)
23. Burke, J. E., and Dennis, E. A. (2009) Phospholipase A2 structure/function, mechanism, and signaling. J. Lipid Res. 50(Suppl.), S237-S242
24. Lucas, K. K., and Dennis, E. A. (2005) Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 77, 235-248 (Pubitemid 41133432)
25. Murakami, M., and Kudo, I. (2001) Diversity and regulatory functions of mammalian secretory phospholipase A2s. Adv. Immunol. 77, 163-194 (Pubitemid 33703706)
26. Yu, L., Deems, R. A., Hajdu, J., and Dennis, E. A. (1990) The interaction of phospholipase A2 with phospholipid analogues and inhibitors. J. Biol. Chem. 265, 2657-2664
27. Liu, C., Yu, S., Zinn, K., Wang, J., Zhang, L., Jia, Y., Kappes, J. C., Barnes, S., Kimberly, R. P., Grizzle, W. E., and Zhang, H. G. (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176, 1375-1385 (Pubitemid 43134279)
28. Mills, G. B., and Moolenaar, W. H. (2003) The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591 (Pubitemid 37328830)
29. Houben, A. J., and Moolenaar, W. H. (2011) Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 30, 557-565
30. Brown, D. P., Gokmen-Polar, Y., Jiang, L., Tan, J., Ringham, H., Janecki, D. J., Qi, G., Witzmann, F. A., Sledge, G. W., Jr., and Wang, M. (2007) A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells. Proteomics Clin. Appl. 1, 18-31
31. Kim, K. S., Sengupta, S., Berk, M., Kwak, Y. G., Escobar, P. F., Belinson, J., Mok, S. C., and Xu, Y. (2006) Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. 66, 7983-7990 (Pubitemid 44299162)
32. Li, H., Wang, D., Zhang, H., Kirmani, K., Zhao, Z., Steinmetz, R., and Xu, Y. (2009) Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice. Mol. Cancer Ther. 8, 1692-1701
33. Xu, Y., Sengupta, S., Singh, S., and Steinmetz, R. (2006) Novel lipid signaling pathways in ovarian cancer cells. Cell Sci. Rev. 3, 168-197
34. Li, H., Zhao, Z., Antalis, C., Emerson, R., Wei, G., Zhang, S., Zhang, Z. Y., and Xu, Y. (2011) Combination therapy of an inhibitor of group via phospholipase A(2) with paclitaxel is highly effective in blocking ovarian cancer development. Am. J. Pathol. 179, 452-461
35. Ren, J., Xiao, Y. J., Singh, L. S., Zhao, X., Zhao, Z., Feng, L., Rose, T. M., Prestwich, G. D., and Xu, Y. (2006) Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 66, 3006-3014
36. Mills, G. B., May, C., Hill, M., Campbell, S., Shaw, P., and Marks, A. (1990) Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J. Clin. Invest. 86, 851-855 (Pubitemid 20327375)
37. Merendino, A. M., Bucchieri, F., Campanella, C., Marciano, V., Ribbene, A., David, S., Zummo, G., Burgio, G., Corona, D. F., Conway de Macario, E., Macario, A. J., and Cappello, F. (2010) Hsp60 is actively secreted by human tumor cells. PLoS One 5, e9247
38. Kobayashi, N., Yamaguchi, A., and Nishi, T. (2009) Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J. Biol. Chem. 284, 21192-21200
39. Burke, J. E., and Dennis, E. A. (2009) Phospholipase A2 biochemistry. Cardiovasc. Drugs Ther. 23, 49-59
40. Goetzl, E. J., Lee, H., Azuma, T., Stossel, T. P., Turck, C. W., and Karliner, J. S. (2000) Gelsolin binding and cellular presentation of lysophosphatidic acid. J. Biol. Chem. 275, 14573-14578 (Pubitemid 30339747)
41. Colin-Santana, C. C., Avendano-Vazquez, S. E., Alcantara-Hernandez, R., and Garcia-Sainz, J. A. (2011) EGF and angiotensin II modulate lysophosphatidic acid LPA(1) receptor function and phosphorylation state. Biochim. Biophys. Acta 1810, 1170-1177
42. Snider, A. J., Zhang, Z., Xie, Y., and Meier, K. E. (2010) Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation. Am. J. Physiol. Cell Physiol. 298, C163-C170
43. Goetzl, E. J., Lee, H., Dolezalova, H., Kalli, K. R., Conover, C. A., Hu, Y. L., Azuma, T., Stossel, T. P., Karliner, J. S., and Jaffe, R. B. (2000) Mechanisms of lysolipid phosphate effects on cellular survival and proliferation. Ann. N. Y. Acad. Sci. 905, 177-187 (Pubitemid 30255417)
44. Samadi, N., Bekele, R., Capatos, D., Venkatraman, G., Sariahmetoglu, M., and Brindley, D. N. (2011) Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie (Paris) 93, 61-70
45. Inoue, S., Iida, T., Tanikawa, T., Maruyama, T., and Morita, C. (1991) Isolation of Listeria monocytogenes from roof rats (Rattus rattus) in buildings in Tokyo. J. Vet. Med. Sci./Japan Soc. Vet. Sci. 53, 521-522
46. Lee, Z., Cheng, C. T., Zhang, H., Subler, M. A., Wu, J., Mukherjee, A., Windle, J. J., Chen, C. K., and Fang, X. (2008) Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol. Biol. Cell 19, 5435-5445